Optinose (OPTN) announced that it will effect a 1-for-15 reverse stock split on December 30, 2024. Beginning with the opening of trading on December 31, 2024, Optinose’s common stock will trade on the Nasdaq Global Select Market on a split-adjusted basis under a new CUSIP number 68404V209 and Optinose’s existing trading symbol “OPTN.”
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OPTN:
- Optinose price target lowered to $1 from $3 at Piper Sandler
- Optinose Shows Prescription Growth Amid Revenue Challenges
- Optinose reports Q3 EPS 0c, consensus (5c)
- Optinose cuts FY24 XHANCE revenue view to $75M-$79M from $85M-$90M
- Is OPTN a Buy, Before Earnings?
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
